针对与激素相关的信号来重编程乳腺癌中抗瘤免疫反应:研究进展和应用前景
Shunchao Yan1, Zhijie Zhang1, Jiale Ji1
1Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Biochimica et biophysica acta. Reviews on cancer
|July 20, 2025
概括
激素疗法可以重新编程乳腺癌瘤微环境,增强抗瘤免疫力. 了解这些机制是提高乳腺癌患者免疫疗法疗效的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 乳腺癌对荷尔蒙和免疫疗法的反应异质.
- 瘤通常被认为是"冷",但荷尔蒙信号调节免疫微环境.
- 激素疗法可以增强抗瘤免疫力,并减少免疫抑制细胞.
研究的目的:
- 探索激素信号与乳腺癌中的抗瘤免疫之间的相互作用.
- 概述研究进展和准与激素相关信号的应用.
- 为了应对挑战和改善免疫疗法疗效的未来方向.
主要方法:
- 对荷尔蒙信号和乳腺癌免疫力研究的文献综述.
- 对激素和抗激素疗法的免疫调节作用的分析.
- 探索重编程瘤免疫微环境的机制.
主要成果:
- 激素信号在乳腺癌中显著影响瘤免疫微环境.
- 抗激素治疗显示有潜力增强抗瘤免疫细胞活性.
- 证据表明,在荷尔蒙影响下演变的动态免疫反应.
结论:
- 针对与激素相关的信号提供了一个有希望的策略,以增强乳腺癌免疫疗法.
- 需要进一步的研究才能充分理解和利用这些复杂的相互作用.
- 优化激素信号调节可以改善乳腺癌患者的治疗结果.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.9K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
